Literature DB >> 3190462

Gross-structural defects in rats after acyclovir application on day 10 of gestation.

I Chahoud1, R Stahlmann, G Bochert, I Dillmann, D Neubert.   

Abstract

Following three s.c. injections of acyclovir (100 mg acyclovir/kg) into rats on day 10 of pregnancy 19 litters were evaluated on day 21 of gestation and the effects were compared to the results obtained from controls (nine litters) which received the vehicle (0.1 N NaOH) only. The following results were obtained (treated group versus control group): 1) Implantations/litter: 11.2 +/- 1.3 versus 10.2 +/- 1.1; 2) resorptions/implantations: 27.7% versus 2.2%; 3) number of viable fetuses evaluated: 154 versus 90; 4) fetuses with anomalies of the skull: 78% versus 12%; 5) fetuses with anomalies of the vertebral column: 38% versus 13%; 6) gross-structural anomalies predominantly affected the skull and tail. The most frequently registered defects were: os tympanicum (smaller): 23%, os tympanicum (missing): 23%; missing tail: 7%; protruding tongue (15%); none of these defects were seen in the control fetuses. Postnatally we observed a high mortality rate among the offspring. From a total of 85 newborn (nine litters) we obtained 73 viable offspring (9.1 +/- 3.4); 81% of them had tail alterations. In the control group of eight litters (9.4 +/- 2.3) no tail alterations occurred. On day 21 postnatally 40 viable offspring were alive (mortality rate: 38.8%). Nearly all of these animals had visible alterations at multiple sites of their bodies; most frequently observed were: tail impairment, closed eyes, dragging hind-limbs, and urogenital alterations (e.g. testicular atrophy). These studies how for the first time that prenatal treatment with acyclovir induces gross-structural defects which persist postnatally.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190462     DOI: 10.1007/bf00316250

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  21 in total

1.  The teratogenic response of the mouse embryo to 5-iododeoxyuridine.

Authors:  R G Skalko; D S Packard
Journal:  Experientia       Date:  1973-02-15

Review 2.  Principles and problems in assessing prenatal toxicity.

Authors:  D Neubert; I Chahoud; T Platzek; R Meister
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

3.  Acyclovir kinetics after intravenous infusion.

Authors:  P de Miranda; R J Whitley; M R Blum; R E Keeney; N Barton; D M Cocchetto; S Good; G P Hemstreet; L E Kirk; D A Page; G B Elion
Journal:  Clin Pharmacol Ther       Date:  1979-12       Impact factor: 6.875

4.  Preclinical toxicology studies with acyclovir: acute and subchronic tests.

Authors:  W E Tucker; A W Macklin; R J Szot; R E Johnston; G B Elion; P de Miranda; G M Szczech
Journal:  Fundam Appl Toxicol       Date:  1983 Nov-Dec

5.  Preclinical toxicology studies with acyclovir: teratologic, reproductive and neonatal tests.

Authors:  H L Moore; G M Szczech; D E Rodwell; R W Kapp; P de Miranda; W E Tucker
Journal:  Fundam Appl Toxicol       Date:  1983 Nov-Dec

Review 6.  Mechanism of action and selectivity of acyclovir.

Authors:  G B Elion
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

7.  The effect of vidarabine on the development of the offspring of rats, rabbits, and monkeys.

Authors:  J L Schardein; D L Hentz; J A Petrere; J E Fitzgerald; S M Kurtz
Journal:  Teratology       Date:  1977-06

8.  Ocular defects in newborn rats treated with 5-iododeoxyuridine (IUDR).

Authors:  D H Percy; D M Albert; T Amemiya
Journal:  Proc Soc Exp Biol Med       Date:  1973-04

9.  Effect of acyclovir on mammalian embryonic development in culture.

Authors:  S Klug; C Lewandowski; G Blankenburg; H J Merker; D Neubert
Journal:  Arch Toxicol       Date:  1985-12       Impact factor: 5.153

Review 10.  Vidarabine: a preliminary review of its pharmacological properties and therapeutic use.

Authors:  R Whitley; C Alford; F Hess; R Buchanan
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

View more
  6 in total

1.  The prevalence and trends of antiviral medication use during pregnancy in the US: a population-based study of 664,297 deliveries in 2001-2007.

Authors:  Lyndsay A Avalos; Hong Chen; Chunmei Yang; Susan E Andrade; William O Cooper; Craig T Cheetham; Robert L Davis; Sascha Dublin; Tarek A Hammad; Sigal Kaplan; Pamala A Pawloski; Marsha A Raebel; Pamela E Scott; David H Smith; Sengwee Toh; De-Kun Li
Journal:  Matern Child Health J       Date:  2014-01

2.  Cytomegalovirus inhibition of embryonic mouse tooth development: a model of the human amelogenesis imperfecta phenocopy.

Authors:  Tina Jaskoll; George Abichaker; Nolan Jangaard; Pablo Bringas; Michael Melnick
Journal:  Arch Oral Biol       Date:  2008-01-16       Impact factor: 2.633

3.  Effect of aciclovir on the development of the chick embryo in ovo.

Authors:  B Heinrich-Hirsch; D Neubert
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

4.  In vitro and in vivo studies on the prenatal toxicity of five virustatic nucleoside analogues in comparison to aciclovir.

Authors:  S Klug; C Lewandowski; H J Merker; R Stahlmann; L Wildi; D Neubert
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

5.  Abnormal thymus development and impaired function of the immune system in rats after prenatal exposure to aciclovir.

Authors:  R Stahlmann; M Korte; H Van Loveren; J G Vos; R Thiel; D Neubert
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

6.  Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model.

Authors:  Michael Melnick; Edward S Mocarski; George Abichaker; Jing Huang; Tina Jaskoll
Journal:  BMC Dev Biol       Date:  2006-09-07       Impact factor: 1.978

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.